Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Anemia and CYP3A4[original query] |
---|
Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients. Haematologica 2005 Aug 90 (8): 1027-31. Dufour Carlo, Svahn Johanna, Bacigalupo Andrea, Longoni Daniela, Varotto Stefania, Iori Anna Paola, Bagnasco Francesca, Locasciulli Anna, Menna Giuseppe, Ramenghi Ugo, Lanciotti Marina, , |
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jul 27 (21): 3540-6. Gandara David R, Kawaguchi Tomoya, Crowley John, Moon James, Furuse Kiyoyuki, Kawahara Masaaki, Teramukai Satoshi, Ohe Yuichiro, Kubota Kaoru, Williamson Stephen K, Gautschi Oliver, Lenz Heinz Josef, McLeod Howard L, Lara Primo N, Coltman Charles Arthur, Fukuoka Masahiro, Saijo Nagahiro, Fukushima Masanori, Mack Philip |
Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach. Gene 2014 Jun 543 (1): 69-75. Tulsyan Sonam, Chaturvedi Pankaj, Singh Abhishek Kumar, Agarwal Gaurav, Lal Punita, Agrawal Sushma, Mittal Rama Devi, Mittal Balr |
SNPs and taxane toxicity in breast cancer patients. Pharmacogenomics 2014 15 (15): 1845-58. Bosó Virginia, Herrero María José, Santaballa Ana, Palomar Laura, Megias Juan E, de la Cueva Helena, Rojas Luis, Marqués María Remedios, Poveda José Luis, Montalar Joaquin, Aliño Salvador |
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect. Frontiers in pharmacology 2017 1 7 494. Ing Lorenzini Kuntheavy, Daali Youssef, Fontana Pierre, Desmeules Jules, Samer Caroli |
Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients. Frontiers in pharmacology 2019 10 206. Lavanderos María A, Cayún Juan P, Roco Ángela, Sandoval Christopher, Cerpa Leslie, Rubilar Juan C, Cerro Roberto, Molina-Mellico Sebastián, Celedón Cesar, Cerda Berta, García-Martín Elena, Agúndez José A G, Acevedo Cristián, Peña Karina, Cáceres Dante D, Varela Nelson M, Quiñones Luis |
Sickle Cell Anemia: Variants in the CYP2D6, CAT, and SLC14A1 Genes Are Associated With Improved Hydroxyurea Response. Frontiers in pharmacology 2020 10 11 553064. Yahouédéhou Sètondji Cocou Modeste Alexandre, Neres Joelma Santana Dos Santos, da Guarda Caroline Conceição, Carvalho Suellen Pinheiro, Santiago Rayra Pereira, Figueiredo Camylla Vilas Boas, Fiuza Luciana Magalhães, Ndidi Uche Samuel, de Oliveira Rodrigo Mota, Fonseca Cleverson Alves, Nascimento Valma Maria Lopes, Rocha Larissa Carneiro, Adanho Corynne Stéphanie Ahouéfa, da Rocha Tiago Santos Carvalho, Adorno Elisângela Vitória, Goncalves Marilda Sou |
Association of CYP2C19, CYP2D6 and CYP3A4 Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients. Pathogens (Basel, Switzerland) 2023 7 12 (7): . Marielle M Macêdo, Anne C G Almeida, Gabrielly S Silva, Amanda C Oliveira, Victor I Mwangi, Ana C Shuan, Laila R A Barbosa, Fernanda Rodrigues-Soares, Gisely C Me |
Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. Cancers 2023 3 15 (5): . Urtasun Andrea, Olivera Gladys G, Sendra Luis, Aliño Salvador F, Berlanga Pablo, Gargallo Pablo, Hervás David, Balaguer Julia, Juan-Ribelles Antonio, Andrés María Del Mar, Cañete Adela, Herrero María Jo |
- Page last reviewed:Feb 1, 2024
- Content source: